Erythropoietin use by incident hemodialysis patients in the Brazilian Unified National Health System, 2002-2003
This study aimed to describe the demographic and epidemiological profile of Brazilian patients entering hemodialysis from 2002 to 2003 and identify predictors of erythropoietin use. The study analyzed demographic and clinical characteristics and dialysis facility-related variables from 32,136 patien...
Gespeichert in:
Veröffentlicht in: | Cadernos de saúde pública 2012-05, Vol.28 (5), p.856-868 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | por |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 868 |
---|---|
container_issue | 5 |
container_start_page | 856 |
container_title | Cadernos de saúde pública |
container_volume | 28 |
creator | Gurgel, Thaís Caroline Cherchiglia, Mariângela Leal Acurcio, Francisco de Assis Szuster, Daniele Araújo Campos Gomes, Isabel Cristina Andrade, Eli Iola Gurgel |
description | This study aimed to describe the demographic and epidemiological profile of Brazilian patients entering hemodialysis from 2002 to 2003 and identify predictors of erythropoietin use. The study analyzed demographic and clinical characteristics and dialysis facility-related variables from 32,136 patients identified by deterministic-probabilistic matching in the database of authorizations for high-cost procedures and the Mortality Information System. Poisson regression was used to identify predictors of erythropoietin use. Male gender, age < 65 years, diabetic renal failure, arteriovenous fistula at the beginning of hemodialysis, and living in States of Brazil other than Mato Grosso were predictors of erythropoietin use. The policy of care for chronic kidney disease, resource allocation for States and municipalities, and anemia management according to the patient's drug therapy profile need to be revised in order to reduce observed inequities in erythropoietin use. |
doi_str_mv | 10.1590/S0102-311X2012000500005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1017759279</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1017759279</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-93baad1dfc82e31b4f27a202d019a5f3d0b1605ab810756720388be4e3b84e3d3</originalsourceid><addsrcrecordid>eNo1kE1LAzEQhoMgtlb_gubowdWZZLMfRy3VCkUPteBtSZpZGtkvN9nD-utdsV6egZmHl5dh7BrhDlUO91tAEJFE_BCAAgAU_OKEzTFJsyiOk3jGzr3_BBBSSHXGZkIkMSrI56xd9WM49G3XOgqu4YMnbkbumr2z1AR-oLq1Tlejd553Orhp6aczDwfij73-dpXTDd81rnRk-etktI2u-Jp0FQ58O_pA9S2faologrxgp6WuPF0e54Ltnlbvy3W0eXt-WT5sog5jDFEujdYWbbnPBEk0cSlSLUBYwFyrUlowmIDSJkNIVZIKkFlmKCZpsglWLtjNX27Xt18D-VDUzu-pqnRD7eALBExTlYs0n9SrozqYmmzR9a7W_Vj8P0n-AH6RaCI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017759279</pqid></control><display><type>article</type><title>Erythropoietin use by incident hemodialysis patients in the Brazilian Unified National Health System, 2002-2003</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Gurgel, Thaís Caroline ; Cherchiglia, Mariângela Leal ; Acurcio, Francisco de Assis ; Szuster, Daniele Araújo Campos ; Gomes, Isabel Cristina ; Andrade, Eli Iola Gurgel</creator><creatorcontrib>Gurgel, Thaís Caroline ; Cherchiglia, Mariângela Leal ; Acurcio, Francisco de Assis ; Szuster, Daniele Araújo Campos ; Gomes, Isabel Cristina ; Andrade, Eli Iola Gurgel</creatorcontrib><description>This study aimed to describe the demographic and epidemiological profile of Brazilian patients entering hemodialysis from 2002 to 2003 and identify predictors of erythropoietin use. The study analyzed demographic and clinical characteristics and dialysis facility-related variables from 32,136 patients identified by deterministic-probabilistic matching in the database of authorizations for high-cost procedures and the Mortality Information System. Poisson regression was used to identify predictors of erythropoietin use. Male gender, age < 65 years, diabetic renal failure, arteriovenous fistula at the beginning of hemodialysis, and living in States of Brazil other than Mato Grosso were predictors of erythropoietin use. The policy of care for chronic kidney disease, resource allocation for States and municipalities, and anemia management according to the patient's drug therapy profile need to be revised in order to reduce observed inequities in erythropoietin use.</description><identifier>EISSN: 1678-4464</identifier><identifier>DOI: 10.1590/S0102-311X2012000500005</identifier><identifier>PMID: 22641509</identifier><language>por</language><publisher>Brazil</publisher><subject>Adolescent ; Adult ; Anemia - drug therapy ; Brazil - epidemiology ; Erythropoietin - therapeutic use ; Female ; Humans ; Kidney Failure, Chronic - blood ; Kidney Failure, Chronic - epidemiology ; Kidney Failure, Chronic - therapy ; Male ; Middle Aged ; Prevalence ; Renal Dialysis ; Risk Factors ; Young Adult</subject><ispartof>Cadernos de saúde pública, 2012-05, Vol.28 (5), p.856-868</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22641509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gurgel, Thaís Caroline</creatorcontrib><creatorcontrib>Cherchiglia, Mariângela Leal</creatorcontrib><creatorcontrib>Acurcio, Francisco de Assis</creatorcontrib><creatorcontrib>Szuster, Daniele Araújo Campos</creatorcontrib><creatorcontrib>Gomes, Isabel Cristina</creatorcontrib><creatorcontrib>Andrade, Eli Iola Gurgel</creatorcontrib><title>Erythropoietin use by incident hemodialysis patients in the Brazilian Unified National Health System, 2002-2003</title><title>Cadernos de saúde pública</title><addtitle>Cad Saude Publica</addtitle><description>This study aimed to describe the demographic and epidemiological profile of Brazilian patients entering hemodialysis from 2002 to 2003 and identify predictors of erythropoietin use. The study analyzed demographic and clinical characteristics and dialysis facility-related variables from 32,136 patients identified by deterministic-probabilistic matching in the database of authorizations for high-cost procedures and the Mortality Information System. Poisson regression was used to identify predictors of erythropoietin use. Male gender, age < 65 years, diabetic renal failure, arteriovenous fistula at the beginning of hemodialysis, and living in States of Brazil other than Mato Grosso were predictors of erythropoietin use. The policy of care for chronic kidney disease, resource allocation for States and municipalities, and anemia management according to the patient's drug therapy profile need to be revised in order to reduce observed inequities in erythropoietin use.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Anemia - drug therapy</subject><subject>Brazil - epidemiology</subject><subject>Erythropoietin - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Kidney Failure, Chronic - blood</subject><subject>Kidney Failure, Chronic - epidemiology</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prevalence</subject><subject>Renal Dialysis</subject><subject>Risk Factors</subject><subject>Young Adult</subject><issn>1678-4464</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE1LAzEQhoMgtlb_gubowdWZZLMfRy3VCkUPteBtSZpZGtkvN9nD-utdsV6egZmHl5dh7BrhDlUO91tAEJFE_BCAAgAU_OKEzTFJsyiOk3jGzr3_BBBSSHXGZkIkMSrI56xd9WM49G3XOgqu4YMnbkbumr2z1AR-oLq1Tlejd553Orhp6aczDwfij73-dpXTDd81rnRk-etktI2u-Jp0FQ58O_pA9S2faologrxgp6WuPF0e54Ltnlbvy3W0eXt-WT5sog5jDFEujdYWbbnPBEk0cSlSLUBYwFyrUlowmIDSJkNIVZIKkFlmKCZpsglWLtjNX27Xt18D-VDUzu-pqnRD7eALBExTlYs0n9SrozqYmmzR9a7W_Vj8P0n-AH6RaCI</recordid><startdate>201205</startdate><enddate>201205</enddate><creator>Gurgel, Thaís Caroline</creator><creator>Cherchiglia, Mariângela Leal</creator><creator>Acurcio, Francisco de Assis</creator><creator>Szuster, Daniele Araújo Campos</creator><creator>Gomes, Isabel Cristina</creator><creator>Andrade, Eli Iola Gurgel</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201205</creationdate><title>Erythropoietin use by incident hemodialysis patients in the Brazilian Unified National Health System, 2002-2003</title><author>Gurgel, Thaís Caroline ; Cherchiglia, Mariângela Leal ; Acurcio, Francisco de Assis ; Szuster, Daniele Araújo Campos ; Gomes, Isabel Cristina ; Andrade, Eli Iola Gurgel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-93baad1dfc82e31b4f27a202d019a5f3d0b1605ab810756720388be4e3b84e3d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>por</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Anemia - drug therapy</topic><topic>Brazil - epidemiology</topic><topic>Erythropoietin - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Kidney Failure, Chronic - blood</topic><topic>Kidney Failure, Chronic - epidemiology</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prevalence</topic><topic>Renal Dialysis</topic><topic>Risk Factors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gurgel, Thaís Caroline</creatorcontrib><creatorcontrib>Cherchiglia, Mariângela Leal</creatorcontrib><creatorcontrib>Acurcio, Francisco de Assis</creatorcontrib><creatorcontrib>Szuster, Daniele Araújo Campos</creatorcontrib><creatorcontrib>Gomes, Isabel Cristina</creatorcontrib><creatorcontrib>Andrade, Eli Iola Gurgel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cadernos de saúde pública</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gurgel, Thaís Caroline</au><au>Cherchiglia, Mariângela Leal</au><au>Acurcio, Francisco de Assis</au><au>Szuster, Daniele Araújo Campos</au><au>Gomes, Isabel Cristina</au><au>Andrade, Eli Iola Gurgel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Erythropoietin use by incident hemodialysis patients in the Brazilian Unified National Health System, 2002-2003</atitle><jtitle>Cadernos de saúde pública</jtitle><addtitle>Cad Saude Publica</addtitle><date>2012-05</date><risdate>2012</risdate><volume>28</volume><issue>5</issue><spage>856</spage><epage>868</epage><pages>856-868</pages><eissn>1678-4464</eissn><abstract>This study aimed to describe the demographic and epidemiological profile of Brazilian patients entering hemodialysis from 2002 to 2003 and identify predictors of erythropoietin use. The study analyzed demographic and clinical characteristics and dialysis facility-related variables from 32,136 patients identified by deterministic-probabilistic matching in the database of authorizations for high-cost procedures and the Mortality Information System. Poisson regression was used to identify predictors of erythropoietin use. Male gender, age < 65 years, diabetic renal failure, arteriovenous fistula at the beginning of hemodialysis, and living in States of Brazil other than Mato Grosso were predictors of erythropoietin use. The policy of care for chronic kidney disease, resource allocation for States and municipalities, and anemia management according to the patient's drug therapy profile need to be revised in order to reduce observed inequities in erythropoietin use.</abstract><cop>Brazil</cop><pmid>22641509</pmid><doi>10.1590/S0102-311X2012000500005</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1678-4464 |
ispartof | Cadernos de saúde pública, 2012-05, Vol.28 (5), p.856-868 |
issn | 1678-4464 |
language | por |
recordid | cdi_proquest_miscellaneous_1017759279 |
source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals |
subjects | Adolescent Adult Anemia - drug therapy Brazil - epidemiology Erythropoietin - therapeutic use Female Humans Kidney Failure, Chronic - blood Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - therapy Male Middle Aged Prevalence Renal Dialysis Risk Factors Young Adult |
title | Erythropoietin use by incident hemodialysis patients in the Brazilian Unified National Health System, 2002-2003 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T09%3A52%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Erythropoietin%20use%20by%20incident%20hemodialysis%20patients%20in%20the%20Brazilian%20Unified%20National%20Health%20System,%202002-2003&rft.jtitle=Cadernos%20de%20sa%C3%BAde%20p%C3%BAblica&rft.au=Gurgel,%20Tha%C3%ADs%20Caroline&rft.date=2012-05&rft.volume=28&rft.issue=5&rft.spage=856&rft.epage=868&rft.pages=856-868&rft.eissn=1678-4464&rft_id=info:doi/10.1590/S0102-311X2012000500005&rft_dat=%3Cproquest_pubme%3E1017759279%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1017759279&rft_id=info:pmid/22641509&rfr_iscdi=true |